PhaseBio Pharmaceuticals phasebio.com


PhaseBio Pharmaceuticals is a clinical-stage biopharmaceutical company developing drugs to treat diabetes and cardiovascular dysfunction in patients suffering from rare diseases. The Company's discovery platform technology uses recombinant ELP biopolymers to control the half-life, bioavailability and physical characteristics of molecules for ease of administration. The resulting compounds are tuned for a specific rate of absorption, thereby increasing efficacy and reducing side effects. The Comp...Show all

PhaseBio Pharmaceuticals is a clinical-stage biopharmaceutical company developing drugs to treat diabetes and cardiovascular dysfunction in patients suffering from rare diseases. The Company's discovery platform technology uses recombinant ELP biopol...Show all

Company (Alive / Active)

Phone: 610-981-6500

Fax:

1 Great Valley Parkway
Suite 30
Malvern, 19355
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
PhaseBio Pharmaceuticals $101.7M Jan 31, 2017
Catalyst Biosciences $111.9M Mar 5, 2015
Biodel $80.1M Feb 18, 2008
See all 17 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related PhaseBio Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 8 investors

Competitors

Company Status Description Investors
See all 17 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Use of modified vasoactive intestinal peptides in the treatment of hypertension Jun 06, 2012 Feb 07, 2017 Patent
Modified vasoactive intestinal peptides Aug 16, 2010 May 12, 2015 Patent
Multimeric elp fusion constructs Jan 04, 2007 May 04, 2010 Patent
Modified vasoactive intestinal peptides Apr 08, 2015 Application
Therapeutic agents comprising insulin amino acid sequences Jun 13, 2014 Application
See all 11 patents